Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Stereotaxis (STXS) EPS (Weighted Average and Diluted) Growth (1y) (2012 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Weighted Avg. Diluted) Growth (1y) (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	18.75%
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	-203.74%
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	10.48%
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	56.10%
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	26.92%
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	23.62%
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	-112.00%
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	-4.27%
10	Stereotaxis	187.40 Mn	172.78 Mn	3.79 Mn	14.29%

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	14.29%
Dec 31, 2025	33.33%
Sep 30, 2025	12.50%
Jun 30, 2025	28.57%
Mar 31, 2025	-16.67%
Dec 31, 2024	-50.00%
Sep 30, 2024	-14.29%
Jun 30, 2024	0.00%
Mar 31, 2024	14.29%
Dec 31, 2023	0.00%
Sep 30, 2023	0.00%
Jun 30, 2023	0.00%
Mar 31, 2023	-16.67%
Dec 31, 2022	-20.00%
Sep 30, 2022	0.00%
Jun 30, 2022	-250.00%
Mar 31, 2022	-200.00%
Dec 31, 2021	-150.00%
Sep 30, 2021	-133.33%
Jun 30, 2021	33.33%
Mar 31, 2021	33.33%
Dec 31, 2020	33.33%
Sep 30, 2020	-481.31%
Jun 30, 2020	0.00%
Mar 31, 2020	25.00%
Dec 31, 2019	-50.00%
Sep 30, 2019	48.39%
Jun 30, 2019	-50.00%
Mar 31, 2019	-500.00%
Dec 31, 2018	83.33%
Sep 30, 2018	95.24%
Jun 30, 2018	0.00%
Mar 31, 2018	0.00%
Dec 31, 2017	-150.00%
Sep 30, 2017	62.50%
Jun 30, 2017	81.82%
Mar 31, 2017	109.09%
Dec 31, 2016	400.00%
Sep 30, 2016	-1,020.00%
Jun 30, 2016	-57.14%
Mar 31, 2016	26.67%
Dec 31, 2015	-300.00%
Jun 30, 2015	30.00%
Mar 31, 2015	28.57%
Dec 31, 2014	117.39%
Jun 30, 2014	72.97%
Mar 31, 2014	65.57%
Dec 31, 2013	58.18%
Sep 30, 2013	-1,696.00%
Jun 30, 2013	-215.63%
Mar 31, 2013	42.45%
Dec 31, 2012	45.00%
Sep 30, 2012	81.20%
Jun 30, 2012	118.08%
Mar 31, 2012	39.43%